Tobacco treatment in the context of lung cancer screening: NRT and text messaging Save

Date Added
August 15th, 2017
PRO Number
Pro00068951
Researcher
Alana Rojewski

Silhouette
Keywords
Cancer/Lung, Lung, Pulmonary, Smoking
Summary

Screening for lung cancer at earlier, more treatable stages has the potential to reduce mortality from the U.S.'s most deadly cancer. Annual lung cancer screening with low-dose computed tomography is now recommended for high risk individuals based on age and smoking history. This study will evaluate a smoking cessation intervention for lung cancer screening patients. We will evaluate quit rates after a standard intervention (brief counseling session at time of LCS) versus a medication and text messaging intervention.

Institution
MUSC
Recruitment Contact
Alana Rojewski
843-876-1593
rojewski@musc.edu

HIV-associated Obstructive Pulmonary Disease and Emphysema Save

Date Added
August 15th, 2017
PRO Number
Pro00066169
Researcher
Lynn Schnapp

Silhouette
Keywords
HIV / AIDS, Pulmonary, Smoking
Summary

Emphysema is a type of Chronic Obstructive Pulmonary Disease (COPD) and a major cause of death. Studies suggest that emphysema is more common in HIV positive people (HIV+) compared to HIV negative (HIV-) people. The purpose of this research study is to determine whether emphysema in HIV+ patients is clinically and biologically different compared to emphysema in those without HIV.

Institution
MUSC
Recruitment Contact
Mary Blanton
8437928438
blantonm@musc.edu

Personalized Smoking Relapse Prevention Delivered in Real-Time via Just-in-Time-Adaptive Interventions: Integrated Tobacco Retail Outlet Location Save

Date Added
February 7th, 2017
PRO Number
Pro00061776
Researcher
Bryan Heckman

Silhouette
Keywords
Smoking
Summary

The study involves use of a new quit-smoking smartphone application. Participants will use the app for two weeks, which involves completing surveys several times a day (approx. 15 min each) and logging any smoking activity. Participants will need to make a nicotine replacement medicine (over-the-counter and study provided) aided quit-attempt. Participants will have the opportunity to make suggestions that may improve the development of the app.

Institution
MUSC
Recruitment Contact
Alexander Hirsch
(843) 640-5698
hirscha@musc.edu

Evaluating smoking and relapse in adolescents and emerging adults using remote monitoring technology Save

Date Added
November 1st, 2016
PRO Number
Pro00060290
Researcher
Erin Mcclure

Silhouette
Keywords
Adolescents, Smoking
Summary

This is a research study that will test a new remote monitoring technology to assess smoking in the natural environment among adolescents and young adults ages 15-25. After assessment and inclusion in the study, participants will be asked to report on their smoking by answering questions on a mobile phone for 35 days. Participants will also be asked to make a brief quit attempt lasting for approximately 48 hours. There is no cost to participate and compensation is available to those who qualify.

Institution
MUSC
Recruitment Contact
Intake Team
843-792-4097
mymobilemonitor@musc.edu

Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP) Save

Date Added
October 18th, 2016
PRO Number
Pro00057768
Researcher
Benjamin Toll

Silhouette
Keywords
Lung, Smoking
Summary

Smoking cessation is the most important strategy available to reduce lung cancer risk. To date, there has been no research on tobacco cessation in lung screening patients, who may have unique attributes (e.g., anxiety about having a nodule coupled with tobacco dependence). We thus propose to evaluate 2 novel behavioral interventions as adjuncts to standard pharmacotherapy. We will enroll and randomize 276 patients undergoing lung screening to Intervention 1 (gain-framed personalized video and print intervention). We will evaluate whether this will improve tobacco quit rates above and beyond standard of care smoking cessation treatment over 8 weeks. Then we will perform a second randomization to Intervention 2, an individual-level, biofeedback intervention. We will then evaluate whether this intervention will reduce smoking rates at 6 months.

Institution
MUSC
Recruitment Contact
Nortorious Coleman
843-509-7589
colemann@musc.edu

Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs Save

Date Added
June 21st, 2016
PRO Number
Pro00055397
Researcher
Benjamin Toll

Silhouette
Keywords
Lung, Pulmonary, Smoking
Summary

This research is a randomized smoking cessation trial conducted within and specifically personalized for lung cancer screening patients presenting to a lung screening clinic. Novel tobacco treatments for this population are critically needed, given the growing population of lung screening patients. In the proposed study, we will test a gain-framed messaging intervention specifically designed for lung screening patients (vs. unframed messaging), as well as evaluating NRT sampling (vs. no medication).

Institution
MUSC
Recruitment Contact
Nortorious Coleman
843-509-7589
colemann@musc.edu

The Watch the Spot Trial Save

Date Added
June 10th, 2016
PRO Number
Pro00044920
Researcher
Gerard Silvestri

Silhouette
Keywords
Cancer, Lung, Pulmonary
Summary

The study will compare two sets of professionally-recommended guidelines for follow-up of patients with small lung nodules. The two guidelines are different in the frequency and timing of follow-up; one is more frequent and the one is less frequent. All patients who have a small lung nodule detected on a chest scan will have a recommended follow-up schedule automatically inserted into their imaging report so that their health care provider may follow the guideline-recommended intervals for follow-up chest scans. Patients and their physicians may choose not to follow the recommendations, depending on preference or the physician's clinical judgment. As part of this research study, information from patients with a small lung nodule who are seen at MUSC will be collected from the electronic medical record. This will include characteristics of the patient (such as age, smoking history), basic information about the lung nodule (such as nodule size, nodule density), and the medical care received.

Institution
MUSC
Recruitment Contact
Katherine Taylor
843-792-2297
taylkat@musc.edu

Evaluating N-acetylcysteine as a pharmacotherapy for tobacco use disorder Save

Date Added
March 1st, 2016
PRO Number
Pro00052793
Researcher
Erin Mcclure

Silhouette
Keywords
Drug Studies, Smoking
Summary

The purpose of this study is to assess the effects of N-Acetylcysteine (NAC), an over-the-counter antioxidant, to assist adult cigarette smokers with quitting and preventing relapse to smoking. This medication may help people quit smoking by reducing withdrawal symptoms, craving, and preventing relapse, but we do not know if NAC helps smokers early in their quit attempt or after they have already quit.

Institution
MUSC
Recruitment Contact
Intake Team
843-792-4097
smokingstudy@musc.edu

Translational Neuropsychopharmacology Research of Nicotine Addiction Save

Date Added
October 20th, 2015
PRO Number
Pro00048152
Researcher
Brett Froeliger

Silhouette
Keywords
Smoking
Summary

This study is investigating the effects of combining 2 medications, Varenicline (commonly known as Chantix®) and N-acetylcysteine, on smoking behavior in daily cigarette smokers who are interested in quitting smoking. The study consists of 10 visits over 6 weeks. Compensation is available for those that qualify. Smokers must be between the ages of 18 and 55.

Institution
MUSC
Recruitment Contact
Shannon Powers
843-882-7196
powerssh@musc.edu

CAROTID REVASCULARIZATION AND MEDICAL MANAGEMENT FOR ASYMPTOMATIC CAROTID STENOSIS TRIAL Save

Date Added
July 6th, 2015
PRO Number
Pro00043906
Researcher
Christine Holmstedt

Silhouette
Keywords
Stroke
Summary

CREST-2 is two parallel multi-center randomized, observer-blinded endpoint clinical trials. One trial will assess treatment differences between intensive medical management alone compared to carotid endarterectomy procedure plus intensive medical management. The parallel trial will assess treatment differences between intensive medical management alone compared to carotid artery stenting plus intensive medical management. Intensive medical management will involve control of blood pressure, LDL cholesterol, cigarette smoking, and other vascular risk factors.

Institution
MUSC
Recruitment Contact
Robert Burfeind
843-792-8606
burfeind@musc.edu

Change_preferences

-- OR --

Create_login